About Us DNA Labs India
DNA Labs India, is a leading molecular diagnostic company dedicated to making a difference in patient’s lives through the discovery and commercialization of transformative tests to assess a person’s risk of developing disease, guide treatment decisions and assess risk of disease progression and recurrence.
The Genetics Division at DNA Labs India provides a comprehensive test menu to assist physicians in the diagnosis of patients with genetic disorders and offers testing in the disciplines of molecular genetics, cytogenetics, fluorescence in situ hybridization (FISH), maternal serum screening, genomic microarray, and biochemical genetics. Committed to providing high-quality genetic testing, DNA Lbas India continuously expands its test menu as new procedures and markers of clinical utility are identified. Medical directors and genetic counselors are available for pre- and post-test consultation and interpretation.
DNA Labs India was founded in 2009 and has since been dedicated to the highest quality genetic and biochemical diagnostic testing for the global medical community. We believe that the molecular understanding of rare disease allows for the coordination of personalized and focused therapy and improved control of rare and congenital disease. This is being supported by the development of very specific and sensitive biomarkers. As one of the world's leading companies in molecular diagnostics, we also support clinicians with expert genetic counseling services and newborn screening. We deliver solutions for your rare disease diagnostics on a laboratory scale
Through the impressive research achievements of our highly qualified staff, molecular geneticists and our molecular diagnostic network, we are making huge contributions in the detection of disorders in patients from around the world. We believe that the best treatment to improve your patient's quality of life and disease state is early detection.
DNA Labs India also collaborates with both academic and industrial partners on the development of new diagnostic techniques and orphan drugs.